These findings suggest that gut microbiota composition and associated metabolites contribute to PAH development by regulating lung tissue gene expression. Our findings have implications for advancing ...

Meanwhile, Altavant’s lead drug is rodatristat ethyl, in mid-stage testing for pulmonary arterial hypertension (PAH), idiopathic ... has re-launched itself as a gene therapy specialist.

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

A powerful storm dropping drenching rain on flood-prone Southern California is raising concern among forecasters that it ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

MSD’s sotatercept has become the first FDA-approved therapy for pulmonary arterial hypertension (PAH) that addresses the underlying mechanism behind the disease, rather than its symptoms.

People admitted to the hospital for atrial fibrillation (AF), first myocardial infarction (MI), and other cardiac conditions have a higher risk of death and a longer average hospital stay if they also ...

Please use one of the following formats to cite this article in your essay, paper or report: APA Sino Biological Inc.. (2025, March 12). Gilead’s capsid revolution meets our capsid solutions ...

The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, ...

A gene regulatory network is a set of genes, or parts of genes, that interact with each other to control a specific cell function. Gene regulatory networks are important in development ...